Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

Wang, Qihui, Zhang, Yanfang, Wu, Lili, Niu, Sheng, Song, Chunli, Zhang, Zengyuan, Lu, Guangwen, Qiao, Chengpeng +6 more·2020·Cell
DOI 10.1016/j.cell.2020.03.045

Cited by (1,009)

Items 401–500 of 1,009

  1. Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes
    Tongqing Zhou, I‐Ting Teng, Adam S. Olia, Gabriele Cerutti, Jason Gorman, Alexandra F. Nazzari, Wei Shi, Yaroslav Tsybovsky, Lingshu Wang, Shuishu Wang et al. · 2020 · Cell Reports
  2. Potential Detrimental Role of Soluble ACE2 in Severe COVID-19 Comorbid Patients
    Mahmudur Rahman, Maruf Hasan, Asif Ahmed · 2020 · Reviews in Medical Virology
  3. Genetically Engineered Cellular Membrane Vesicles as Tailorable Shells for Therapeutics
    En Ren, Chao Liu, Peng Lv, Junqing Wang, Gang Liu · 2021 · Advanced Science
  4. Nanomaterials as Promising Theranostic Tools in Nanomedicine and Their Applications in Clinical Disease Diagnosis and Treatment
    Wei Zhu, Zhanqi Wei, Han Chang, Xisheng Weng · 2021 · Nanomaterials
  5. Tracing the origins of SARS-COV-2 in coronavirus phylogenies: a review
    Erwan Sallard, José Halloy, Didier Casañe, Étienne Decroly, Jacques van Helden · 2021 · Environmental Chemistry Letters
  6. Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein
    Matteo Calcagnile, Patricia Forgez, Antonio Iannelli, Cecilia Bucci, Marco Alifano, Pietro Alifano · 2020 · Biochimie
  7. Antidepressant and Antipsychotic Drugs Reduce Viral Infection by SARS-CoV-2 and Fluoxetine Shows Antiviral Activity Against the Novel Variants in vitro
    Senem Merve Fred, Suvi H. Kuivanen, Hasan Uğurlu, Plinio Cabrera Casarotto, Lev Levanov, Kalle Saksela, Olli P. Vapalahti, Eero Ċastrén · 2022 · Frontiers in Pharmacology
  8. The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein
    Hisham M. Dokainish, Suyong Re, Takaharu Mori, Chigusa Kobayashi, Jaewoon Jung, Yuji Sugita · 2022 · eLife
  9. SARS-CoV-2 spike opening dynamics and energetics reveal the individual roles of glycans and their collective impact
    Yui Tik Pang, Atanu Acharya, Diane L. Lynch, Ànna Pavlova, James C. Gumbart · 2022 · Communications Biology
  10. Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
    Zang, Jinkai, Gu, Chenjian, Zhou, Bingjie, Zhang, Chao, Yang, Yong, Xu, Shiqi, Bai, Lulu, Zhang, Rong, Deng, Qiang, Yuan, Zhenghong et al. · 2020 · Cell Discovery
  11. Genetic Spectrum and Distinct Evolution Patterns of SARS-CoV-2
    Sheng Liu, Jikui Shen, Shuyi Fang, Kailing Li, Juli Liu, Lei Yang, Chang‐Deng Hu, Jun Wan · 2020 · Frontiers in Microbiology
  12. The Potential of lactoferrin, Ovotransferrin and Lysozyme As Antiviral and immune-modulating Agents in COVID-19
    Jaclyn Kelly Mann, Thumbi Ndung’u · 2020 · Future Virology
  13. Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity
    Sandipan Chakraborty · 2021 · Biochemical and Biophysical Research Communications
  14. The SARS-CoV-2 B.1.618 variant slightly alters the spike RBD–ACE2 binding affinity and is an antibody escaping variant: a computational structural perspective
    Abbas Khan, Jianjun Gui, Waqar Ahmad, Inamul Haq, Marukh Shahid, Awais Ahmed Khan, Abdullah Shah, Arsala Khan, Liaqat Ali, Zeeshan Anwar et al. · 2021 · RSC Advances
  15. Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions
    Yujie Jiang, Tingmei Zhao, Xueyan Zhou, Xiang Yu, Pedro Gutiérrez‐Castrellón, Xuelei Ma · 2022 · MedComm
  16. Human animal interface of SARS-CoV-2 (COVID-19) transmission: a critical appraisal of scientific evidence
    Rubal Singla, Abhishek Mishra, Rupa Joshi, Sonali Jha, Amit Raj Sharma, Sujata Upadhyay, Phulen Sarma, Ajay Prakash, Bikash Medhi · 2020 · Veterinary Research Communications
  17. Molecular Simulations and Network Modeling Reveal an Allosteric Signaling in the SARS-CoV‑2 Spike Proteins
    Gennady M. Verkhivker · 2020 · Journal of Proteome Research
  18. Molecular basis of cross‐species ACE2 interactions with SARS‐CoV‐2‐like viruses of pangolin origin
    Sheng Niu, Jia Wang, Bin Bai, Lili Wu, Anqi Zheng, Qian Chen, Pei Du, Pengcheng Han, Yanfang Zhang, Yunfei Jia et al. · 2021 · The EMBO Journal
  19. Tagged extracellular vesicles with the RBD of the viral spike protein for delivery of antiviral agents against SARS-COV-2 infection
    Yuxuan Fu, Sidong Xiong · 2021 · Journal of Controlled Release
  20. Free Energy Landscapes from SARS-CoV-2 Spike Glycoprotein Simulations Suggest that RBD Opening Can Be Modulated via Interactions in an Allosteric Pocket
    Lucy Fallon, Kellon A. A. Belfon, Lauren E. Raguette, Yuzhang Wang, Darya Stepanenko, Abbigayle E. Cuomo, Jose Guerra, Stephanie Budhan, Sarah Varghese, Christopher P. Corbo et al. · 2021 · Journal of the American Chemical Society
  21. Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals
    Yuanmei Zhu, Danwei Yu, Yang Han, Hongxia Yan, Huihui Chong, Lili Ren, Jianwei Wang, Taisheng Li, Yuxian He · 2020 · Science Advances
  22. Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs
    Jacob B. Pierce, Viorel Simion, Basak Icli, Daniel Pérez‐Cremades, Henry S. Cheng, Mark W. Feinberg · 2020 · Genes
  23. Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies
    M. Finkelstein, Adam G. Mermelstein, Emma Parker Miller, P. Seth, Erik-Stephane D. Stancofski, D. Fera · 2021 · Viruses
  24. Computational Design of Potent D-Peptide Inhibitors of SARS-CoV-2
    Pedro Alberto Valiente, Han Wen, Satra Nim, JinAh Lee, Hyeon Ju Kim, Jinhee Kim, Albert Perez‐Riba, Yagya Prasad Paudel, Insu Hwang, Kyun‐Do Kim et al. · 2021 · Journal of Medicinal Chemistry
  25. Genomic Perspectives on the Emerging SARS-CoV-2 Omicron Variant
    Wentai Ma, Jing Yang, Haoyi Fu, Chao Su, Caixia Yu, Qihui Wang, Ana Tereza Ribeiro de Vasconcelos, Georgii A. Bazykin, Yīmíng Bào, Mingkun Li · 2022 · Genomics Proteomics & Bioinformatics
  26. SARS-CoV-2 ORF9c Is a Membrane-Associated Protein that Suppresses Antiviral Responses in Cells
    Ana Dominguez Andres, Yongmei Feng, Alexandre Rosa Campos, Jun Yin, Chih-Cheng Yang, Brian P. James, Rabi Murad, Hyungsoo Kim, Aniruddha J. Deshpande, David Ezra Gordon et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  27. SARS-CoV-2 and cancer: Are they really partners in crime?
    Peter A. van Dam, Manon Thirza Huizing, Gino Mestach, Stazie Dierckxsens, Wiebren A.A. Tjalma, Xuan Bich Trinh, Kostantinos Papadimitriou, Sevilay Altıntaş, Jan Baptist Vermorken, Christof Vulsteke et al. · 2020 · Cancer Treatment Reviews
  28. The Association of Subacute Thyroiditis with COVID-19: a Systematic Review
    Muhammad Aemaz Ur Rehman, Hareem Farooq, Muhammad Mohsin Ali, Muhammad Ebaad Ur Rehman, Qudsia Anwar Dar, Awab Hussain · 2021 · SN Comprehensive Clinical Medicine
  29. “SLC-omics” of the kidney: solute transporters along the nephron
    Spencer A. Lewis, Lihe Chen, Viswanathan Raghuram, Syed Jalal Khundmiri, Chung‐Lin Chou, Chin‐Rang Yang, Mark A. Knepper · 2021 · American Journal of Physiology-Cell Physiology
  30. SARS-CoV-2 down-regulates ACE2 through lysosomal degradation
    Yi Lu, Qingwei Zhu, Douglas Fox, Carol Gao, Sarah A. Stanley, Kunxin Luo · 2022 · Molecular Biology of the Cell
  31. Evidence Supporting the Use of Peptides and Peptidomimetics As Potential SARS-CoV-2 (COVID-19) Therapeutics
    Sonya VanPatten, Mingzhu He, Ahmad S. Altiti, Kai Fan Cheng, Mustafa H. Ghanem, Yousef Al‐Abed · 2020 · Future Medicinal Chemistry
  32. Quantitative determination of mechanical stability in the novel coronavirus spike protein
    Rodrigo A. Moreira, Mateusz Chwastyk, Joseph L. Baker, Horacio V. Guzman, Adolfo B. Poma · 2020 · Nanoscale
  33. COVID-19: age, Interleukin-6, C-reactive protein, and lymphocytes as key clues from a multicentre retrospective study
    Aurora Jurado, María C. Martín, Cristina Abad‐Molina, Antonio Orduña, Alba Martínez, Esther Ocaña, Oscar Yarce, Ana M. Navas, Antonio Trujillo-Aguilera, Luis Fernández et al. · 2020 · Immunity & Ageing
  34. Coronavirus Interplay With Lipid Rafts and Autophagy Unveils Promising Therapeutic Targets
    Katia Fecchi, Simona Anticoli, Daniela Peruzzu, Elisabetta Iessi, Maria Cristina Gagliardi, Paola Matarrese, Anna Ruggieri · 2020 · Frontiers in Microbiology
  35. Occurrence, fate and removal of SARS-CoV-2 in wastewater: Current knowledge and future perspectives
    Bhavini Saawarn, Subrata Hait · 2020 · Journal of environmental chemical engineering
  36. In silico virtual screening-based study of nutraceuticals predicts the therapeutic potentials of folic acid and its derivatives against COVID-19
    Vipul Kumar, Sudhakar Kancharla, Manoj Kumar Jena · 2021 · VirusDisease
  37. Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class
    Micah Rapp, Yicheng Guo, Eswar R. Reddem, Jian Yu, Lihong Liu, Pengfei Wang, Gabriele Cerutti, Phinikoula S. Katsamba, Jude Saber Bimela, Fabiana A. Bahna et al. · 2021 · Cell Reports
  38. Integrated Biophysical Modeling of the SARS-CoV-2 Spike Protein Binding and Allosteric Interactions with Antibodies
    Gennady M. Verkhivker, Luisa Di Paola · 2021 · The Journal of Physical Chemistry B
  39. Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein
    Robert J. Ragotte, David Pulido, Francesca R. Donnellan, Michelle L. Hill, Giacomo Gorini, H. Dele Davies, Juliane Brun, Kirsty McHugh, Lloyd D. W. King, Katherine Skinner et al. · 2021 · mSphere
  40. SARS-CoV-2 Delta (B.1.617.2) Variant: A Unique T478K Mutation in Receptor Binding Motif (RBM) of Spike Gene
    Hyunjhung Jhun, Ho‐Young Park, Yasmin Hisham, Chang‐Seon Song, Soohyun Kim · 2021 · Immune Network
  41. The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape
    Pedro Filho Noronha Souza, Felipe Pantoja Mesquita, Jackson L. Amaral, Patrícia G.C. Landim, Karollyny Roger Pereira Lima, Marília Braga Costa, Izabelle Rocha Farias, Mônica O. Belém, Yago O. Pinto, H. H. T. Moreira et al. · 2022 · International Journal of Biological Macromolecules
  42. Genetic polymorphisms associated with susceptibility to COVID-19 disease and severity: A systematic review and meta-analysis
    Cristine Dieter, Letícia de Almeida Brondani, C. Leitão, F. Gerchman, N. E. Lemos, Daisy Crispim · 2022 · PLoS ONE
  43. Covalent Organic Frameworks (COFs) as Multi-Target Multifunctional Frameworks
    Syed Nasir Abbas Bukhari, Naveed Ahmed, Muhammad Wahab Amjad, Muhammad Ajaz Hussain, Mervat A. Elsherif, Hasan Ejaz, Nasser Hadal Alotaibi · 2023 · Polymers
  44. Can SARS-CoV-2 Accumulate Mutations in the S-Protein to Increase Pathogenicity?
    Aditya Kumar Padhi, Timir Tripathi · 2020 · ACS Pharmacology & Translational Science
  45. Molecular mechanisms and epidemiology of COVID-19 from an allergist’s perspective
    Hosoki, Koa, Chakraborty, Abhijit, Sur, Sanjiv · 2020 · Journal of Allergy and Clinical Immunology
  46. Single‐cell RNA expression profiling of SARS‐CoV‐2‐related ACE2 and TMPRSS2 in human trophectoderm and placenta
    Dan Cui, Y. Liu, Xiangxiang Jiang, Chunming Ding, Liona C. Poon, H. Wang, Huixia Yang · 2020 · Ultrasound in Obstetrics and Gynecology
  47. Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19
    Selin Gencer, Michael Lacy, Dorothee Atzler, Emiel P. C. van der Vorst, Yvonne Döring, Christian Weber · 2020 · Thrombosis and Haemostasis
  48. Critical Sequence Hotspots for Binding of Novel Coronavirus to Angiotensin Converter Enzyme as Evaluated by Molecular Simulations
    Mahdi Ghorbani, Bernard R. Brooks, Jeffery B. Klauda · 2020 · The Journal of Physical Chemistry B
  49. Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions
    Nikolaos Alexandris, George Lagoumintzis, Christos T. Chasapis, Demetres D. Leonidas, Georgios E. Papadopoulos, Socrates J. Tzartos, Aristidis Michael Tsatsakis, Elias Eliopoulos, Konstantinos A. Poulas, Konstantinos E. Farsalinos · 2020 · Toxicology Reports
  50. Dynamic Network Modeling of Allosteric Interactions and Communication Pathways in the SARS-CoV-2 Spike Trimer Mutants: Differential Modulation of Conformational Landscapes and Signal Transmission via Cascades of Regulatory Switches
    Gennady M. Verkhivker, Luisa Di Paola · 2021 · The Journal of Physical Chemistry B
  51. A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants
    Yanyun Du, Rui Shi, Ying Zhang, Xiaomin Duan, Li Li, Jing Zhang, Fengze Wang, Ruixue Zhang, Hao Shen, Yue Wang et al. · 2021 · Nature Communications
  52. Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions
    Ying Han, Kai Yuan, Zhe Wang, Weijian Liu, Zheng-An Lu, Lin Liu, Le Shi, Wei Yan, Junliang Yuan, Jiali Li et al. · 2021 · Translational Psychiatry
  53. Fighting COVID-19 Using Molecular Dynamics Simulations
    Pablo Ricardo Arantes, Aakash Saha, Giulia Palermo · 2020 · ACS Central Science
  54. Structural genetics of circulating variants affecting the SARS-CoV-2 spike/human ACE2 complex
    Francesco Ortuso, Daniele Mercatelli, Pietro Hiram Guzzi, Federico Manuel Giorgi · 2021 · Journal of Biomolecular Structure and Dynamics
  55. Sterically confined rearrangements of SARS-CoV-2 Spike protein control cell invasion
    Esteban Dodero‐Rojas, José N. Onuchic, Paul C. Whitford · 2021 · eLife
  56. Genomic Variations in the Structural Proteins of SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative Genomics Approach
    Taj Mohammad, Arunabh Choudhury, Insan Habib, Purva Asrani, Yash Mathur, Mohd Umair, Farah Anjum, Alaa Shafie, Dharmendra Kumar Yadav, Md. Imtaiyaz Hassan · 2021 · Frontiers in Cellular and Infection Microbiology
  57. A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19
    Essa M. Saied, Yousra A. El‐Maradny, Alaa A. Osman, Amira M.G. Darwish, Hebatallah H. Abo Nahas, Gniewko Niedbała, Magdalena Piekutowska, Mohamed A. Abdel-Rahman, Bassem A. Balbool, Ahmed M. Abdel-Azeem · 2021 · Pharmaceutics
  58. Gold-silver alloy hollow nanoshells-based lateral flow immunoassay for colorimetric, photothermal, and SERS tri-mode detection of SARS-CoV-2 neutralizing antibody
    Tianyu Zhao, Penghui Liang, Jiaqi Ren, Jinyue Zhu, Xianning Yang, Hongyu Bian, Jingwen Li, Xiaofeng Cui, Chunhui Fu, Jinyan Xing et al. · 2023 · Analytica Chimica Acta
  59. Cryo-EM structures of HKU2 and SADS-CoV spike glycoproteins provide insights into coronavirus evolution
    Jinfang Yu, Shuyuan Qiao, Runyu Guo, Xinquan Wang · 2020 · Nature Communications
  60. The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates
    Da-Peng Li, R. Edwards, K. Manne, David R. Martinez, A. Schäfer, S. Alam, K. Wiehe, Xiao-Zhi Lu, Robert Parks, Laura L. Sutherland et al. · 2021 · bioRxiv
  61. Genomic variation, origin tracing, and vaccine development of SARS-CoV-2: A systematic review
    Tianbao Li, Tao Huang, Cheng Guo, Ailan Wang, Xiaoli Shi, Xiaofei Mo, Qingqing Lu, Jing Sun, Tingting Hui, Geng Tian et al. · 2021 · The Innovation
  62. Disulfide Bonds Play a Critical Role in the Structure and Function of the Receptor-binding Domain of the SARS-CoV-2 Spike Antigen
    Andrey M. Grishin, Natalia V. Dolgova, Shelby L. Landreth, Olivier Fisette, Ingrid J. Pickering, Graham Neil George, Darryl Falzarano, Mirosław Cygler · 2021 · Journal of Molecular Biology
  63. Millisecond dynamic of SARS‐CoV‐2 spike and its interaction with ACE2 receptor and small extracellular vesicles
    Keesiang Lim, Goro Nishide, Takeshi Yoshida, Takahiro Watanabe‐Nakayama, Akiko Kobayashi, Masaharu Hazawa, Rikinari Hanayama, Toshio Ando, Richard Wing-Chuen Wong · 2021 · Journal of Extracellular Vesicles
  64. An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigen
    Miladys Limonta Fernández, Glay Chinea Santiago, Alejandro Miguel Martín-Dunn, Diamile Gonzalez-Roche, Mónica Béquet‐Romero, Gabriel Márquez, Isabel González-Moya, Camila Canaán-Haden, Ania Cabrales, Luis Ariel Espinosa et al. · 2022 · New Biotechnology
  65. The COVID-19 pandemic and Alzheimer’s disease: mutual risks and mechanisms
    Feng Chen, Yan‐Ting Chen, Yongxiang Wang, Qiongwei Ke, Lili Cui · 2022 · Translational Neurodegeneration
  66. Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design
    Dongliang Wang, Jinhui Mai, Wenfeng Zhou, Wanting Yu, Yang Zhan, Naidong Wang, Neal D. Epstein, Yi Yang · 2020 · Vaccines
  67. The Wide Spectrum of COVID-19 Clinical Presentation in Children
    Nadia Nathan, Blandine Prévost, Chiara Siléo, Nicolas Richard, Laura Berdah, Guillaume Thouvenin, Guillaume Aubertin, Thibault Lecarpentier, Aurélie Schnuriger, Julien Jegard et al. · 2020 · Journal of Clinical Medicine
  68. Coronavirus disease 2019 and the pancreas
    Jayanta Samanta, Rohit Kumar Gupta, Mini Pritam Singh, Itish Patnaik, Ashok S. Kumar, Rakesh K. Kochhar · 2020 · Pancreatology
  69. Identification of a repurposed drug as an inhibitor of Spike protein of human coronavirus SARS-CoV-2 by computational methods
    Sruthi Unni, Snehal Aouti, Saravanamuthu Thiyagarajan, Balasundaram Padmanabhan · 2020 · Journal of Biosciences
  70. Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome
    Rodrigo Cerqueira Borges, Miriam Sayuri Hohmann, Sérgio M. Borghi · 2020 · International Reviews of Immunology
  71. Insights on cross-species transmission of SARS-CoV-2 from structural modeling
    João Rodrigues, Susana Barrera-Vilarmau, João M. C. Teixeira, Marija Sorokina, Elizabeth Seckel, Panagiotis L. Kastritis, Michael Levitt · 2020 · PLoS Computational Biology
  72. Sphingolipids as Modulators of SARS-CoV-2 Infection
    Kid Törnquist, Muhammad Yasir Asghar, Vignesh Srinivasan, Laura Korhonen, Dan Lindholm · 2021 · Frontiers in Cell and Developmental Biology
  73. Marine Sulfated Polysaccharides as Promising Antiviral Agents: A Comprehensive Report and Modeling Study Focusing on SARS CoV-2
    Abdalla E. M. Salih, Bathini Thissera, Mohammed Yaseen, Ahmed S. I. Hassane, Hesham Rushdey El-Seedi, Ahmed M. Sayed, Mostafa Ezzat Rateb · 2021 · Marine Drugs
  74. Role of ACE2 in pregnancy and potential implications for COVID-19 susceptibility
    Nayara Azinheira Nobrega Cruz, Danielle Stoll, Dulce Elena Casarini, Mariane Bertagnolli · 2021 · Clinical Science
  75. Therapeutic potential of targeting LSD1/ KDM1A in cancers
    Xiangyu Zhang, Xinran Wang, Tianxiao Wu, Wenbo Yin, Jiangkun Yan, Yixiang Sun, Dongmei Zhao · 2021 · Pharmacological Research
  76. Antigenic characterization of influenza and SARS-CoV-2 viruses
    Yang Wang, Cynthia Y. Tang, Xiu‐Feng Wan · 2021 · Analytical and Bioanalytical Chemistry
  77. Emerging genetic diversity among clinical isolates of SARS-CoV-2: Lessons for today
    Javaid Ahmad Sheikh, Jasdeep Singh, Hina Singh, Salma Jamal, Mohd Khubaib, Sunil Kohli, Ulrich Dobrindt, Syed Asad Rahman, Nasreen Z. Ehtesham, Seyed E. Hasnain · 2020 · Infection Genetics and Evolution
  78. SARS-CoV-2, More than a Respiratory Virus: Its Potential Role in Neuropathogenesis
    Chitra Mohinder Singh Singal, Paritosh Jaiswal, Pankaj Seth · 2020 · ACS Chemical Neuroscience
  79. Recent insights for the emerging COVID-19: Drug discovery, therapeutic options and vaccine development
    Yue-Fei Zhu, Jia Li, Z. Pang · 2020 · Asian Journal of Pharmaceutical Sciences
  80. SARS‐CoV‐2, Covid‐19, and the debunking of conspiracy theories
    Mohamad Saifudin Hakim · 2021 · Reviews in Medical Virology
  81. Molecular Aspects Concerning the Use of the SARS-CoV‑2 Receptor Binding Domain as a Target for Preventive Vaccines
    Yury Valdés-Balbín, Darielys Santana-Mederos, Françoise Paquet, Sonsire Fernández-Castillo, Yanet Climent, Fabrizio Chiodo, Laura Rodríguez, Belinda Sánchez Ramírez, Kalet León, Tays Hernández et al. · 2021 · ACS Central Science
  82. Development and application of therapeutic antibodies against COVID-19
    Lin-jin Ning, H. B. Abagna, Qianhu Jiang, Siqi Liu, Jian Huang · 2021 · International Journal on Biological Sciences
  83. Yeast-produced RBD-based recombinant protein vaccines elicit broadly neutralizing antibodies and durable protective immunity against SARS-CoV-2 infection
    Jinkai Zang, Yuanfei Zhu, Yu Zhou, Chenjian Gu, Yufang Yi, Shuxia Wang, Shiqi Xu, Gaowei Hu, Shujuan Du, Yannan Yin et al. · 2021 · Cell Discovery
  84. The effect of coronavirus disease 2019 immunity on frozen-thawed embryo transfer cycles outcome
    Adva Aizer, Meirav Noach‐Hirsh, Olga Dratviman‐Storobinsky, Ravit Nahum, Ronit Machtinger, Yuval Yung, Jigal Haas, Raoul Orvieto · 2022 · Fertility and Sterility
  85. Towards an Electrochemical Immunosensor for the Detection of Antibodies against SARS-CoV-2 Spike Protein
    Viktorija Liustrovaitė, Maryia Drobysh, A. Ručinskienė, Aušra Baradokė, Almira Ramanavičienė, Ieva Plikusienė, Urtė Samukaitė-Bubnienė, Roman Viter, Chien‐Fu Chen, Arūnas Ramanavičius · 2022 · Journal of The Electrochemical Society
  86. Clinical grade ACE2 as a universal agent to block SARS‐CoV‐2 variants
    Vanessa Monteil, Brett Eaton, Elena N. Postnikova, Michael J. Murphy, Benedict Braunsfeld, Ian Crozier, Franz Kricek, Janine Niederhöfer, Alice Schwarzböck, Helene Breid et al. · 2022 · EMBO Molecular Medicine
  87. Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination
    Valeria Fumagalli, M. Ravà, D. Marotta, P. Di Lucia, Elisa Bono, Leonardo Giustini, F. De Leo, Maura Casalgrandi, Emanuele Monteleone, Violette Mouro et al. · 2024 · Nature Immunology
  88. Is periodontal disease a risk factor for developing severe Covid-19 infection? The potential role of Galectin-3
    Cankat Kara, Kübra Çelen, Figen Öngöz Dede, Ceren Gökmenoğlu, Nihal Beldüz Kara · 2020 · Experimental Biology and Medicine
  89. SARS-CoV-2 replicates in respiratory ex vivo organ cultures of domestic ruminant species
    Giovanni Di Teodoro, Fabrizia Valleriani, Ilaria Puglia, Federica Monaco, Chiara Di Pancrazio, Mirella Luciani, Ivanka Marinova Krasteva, Antonio Petrini, Maurilia Marcacci, Nicola D’Alterio et al. · 2020 · Veterinary Microbiology
  90. Machine Learning Reveals the Critical Interactions for SARS-CoV-2 Spike Protein Binding to ACE2
    Ànna Pavlova, Zijian Zhang, Atanu Acharya, Diane L. Lynch, Yui Tik Pang, Zhongyu Mou, Jerry M. Parks, Christophe J. Chipot, James C. Gumbart · 2021 · The Journal of Physical Chemistry Letters
  91. Preliminary Structural Data Revealed That the SARS‐CoV‐2 B.1.617 Variant's RBD Binds to ACE2 Receptor Stronger Than the Wild Type to Enhance the Infectivity
    Abbas Khan, Dong‐Qing Wei, Kafila Kousar, Jehad Ahmed Abubaker, Sajjad Ahmad, Javaid Ali, Fahd Al‐Mulla, Syed Shujait Ali, N. Nizam‐Uddin, Abrar Mohammad Sayaf et al. · 2021 · ChemBioChem
  92. Co-existence and co-infection of influenza A viruses and coronaviruses: Public health challenges
    Jing Yang, Yuhuan Gong, Chunge Zhang, Ju Sun, Gary Wong, Weifeng Shi, Wenjun Liu, George F. Gao, Yuhai Bi · 2022 · The Innovation
  93. Probing infectious disease by single-cell RNA sequencing: Progresses and perspectives
    Geyang Luo, Qian Gao, Shuye Zhang, Bo Yan · 2020 · Computational and Structural Biotechnology Journal
  94. Interplay of Opposing Effects of the WNT/β-Catenin Pathway and PPARγ and Implications for SARS-CoV2 Treatment
    Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée · 2021 · Frontiers in Immunology
  95. Impact of South African 501.V2 Variant on SARS-CoV-2 Spike Infectivity and Neutralization: A Structure-based Computational Assessment
    Mary Hongying Cheng, James Krieger, Burak Kaynak, Moshe Arditi, İvet Bahar · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Characterization of Structural and Energetic Differences between Conformations of the SARS-CoV-2 Spike Protein
    Rodrigo A. Moreira, Horacio V. Guzman, Subramanian Boopathi, Joseph L. Baker, Adolfo B. Poma · 2020 · Materials
  97. Nanotechnology-Based Approaches for the Detection of SARS-CoV-2
    Ritika Gupta, Poonam Sagar, Nitesh Priyadarshi, Sunaina Kaul, Rajat Sandhir, Vikas Rishi, Nitin Kumar Singhal · 2020 · Frontiers in Nanotechnology
  98. SNPs of ACE1 (rs4343) and ACE2 (rs2285666) genes are linked to SARS-CoV-2 infection but not with the severity of disease
    Nahid Alimoradi, Moein Sharqi, Dena Firouzabadi, Mohammad Moein Sadeghi, Seyed Mohammad Iman Moezzi, Negar Firouzabadi · 2022 · Virology Journal
  99. Emerging SARS-CoV-2 variants: Why, how, and what's next?
    Yu Zheng Chen, Qianyun Liu, Li Zhou, You Zhou, Huan Yan, Ke Lan · 2022 · Cell Insight
  100. Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity
    Ratul Chowdhury, Veda Sheersh Boorla, Costas D. Maranas · 2020 · Computational and Structural Biotechnology Journal